Biocom Applauds House Passage of Legislation to Repeal the Medical Device Tax
https://www.businesswire.com/news/home/20180724006028/en/
SAN DIEGO--(BUSINESS WIRE)--Jul 24, 2018--Biocom, the association representing the life science industry of California, issued the following statement regarding the passage of H.R. 184, the Protect Medical Innovation Act, in the U.S. House of Representatives by a 283-132 vote. The statement can be attributed to Joe Panetta, Biocom’s president and CEO:
“Today, the House passed legislation to fully and permanently repeal the 2.3 percent medical device excise tax. This bipartisan legislation puts an end to short-term suspensions of the tax which have made it very difficult for medical technology (medtech) innovators to make long-term plans for their development.
Biocom Applauds House Passage of Legislation to Repeal the Medical Device Tax
Jul 25, 2018, 1:28am UTC
https://www.businesswire.com/news/home/20180724006028/en/
> SAN DIEGO--(BUSINESS WIRE)--Jul 24, 2018--Biocom, the association representing the life science industry of California, issued the following statement regarding the passage of H.R. 184, the Protect Medical Innovation Act, in the U.S. House of Representatives by a 283-132 vote. The statement can be attributed to Joe Panetta, Biocom’s president and CEO:
> “Today, the House passed legislation to fully and permanently repeal the 2.3 percent medical device excise tax. This bipartisan legislation puts an end to short-term suspensions of the tax which have made it very difficult for medical technology (medtech) innovators to make long-term plans for their development.